Works matching IS 17762596 AND DT 2019 AND VI 14 AND IP 2

Results: 12

Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.

Published in:

2019

By:

Raschi, Emanuel;
Mazzarella, Alessandra;
Antonazzo, Ippazio Cosimo;
Bendinelli, Nicolò;
Forcesi, Emanuele;
Tuccori, Marco;
Moretti, Ugo;
Poluzzi, Elisabetta;
De Ponti, Fabrizio

Publication type:

journal article

Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.

Published in:

2019

By:

Su, Yudong;
Long, Xiang;
Song, Yang;
Chen, Peng;
Li, Shanqing;
Yang, Huaxia;
Wu, Pancheng;
Wang, Yanyu;
Bing, Zhongxing;
Cao, Zhili;
Cao, Lei;
Wu, Yijun;
Zhang, Zhe;
Liu, Jing;
Li, Bing;
Xiang, Jianxing;
Ma, Ke;
Zhang, Tengfei;
Zhang, Lu;
Mao, Xinru

Publication type:

journal article

Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy.

Published in:

2019

By:

Takagi, Toshio;
Fukuda, Hironori;
Kondo, Tsunenori;
Ishihara, Hiroki;
Yoshida, Kazuhiko;
Kobayashi, Hirohito;
Iizuka, Junpei;
Okumi, Masayoshi;
Ishida, Hideki;
Tanabe, Kazunari

Publication type:

journal article

Comparative Efficacy of CDK4/6 Inhibitors Plus Aromatase Inhibitors Versus Fulvestrant for the First-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer: A Network Meta-Analysis.

Published in:

2019

By:

Guo, Qianqian;
Lin, Xiaojie;
Ye, Lingling;
Xu, Rui;
Dai, Yan;
Zhang, Yuzhu;
Chen, Qianjun

Publication type:

journal article

Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.

Published in:

2019

By:

Hong, Xiaonan;
Song, Yuqin;
Huang, Huiqiang;
Bai, Bing;
Zhang, Huilai;
Ke, Xiaoyan;
Shi, Yuankai;
Zhu, Jun;
Lu, Guodong;
Liebscher, Stefan;
Cai, Chunxiao

Publication type:

journal article

Inhibiting Bruton's Tyrosine Kinase in CLL and Other B-Cell Malignancies.

Published in:

2019

By:

Lucas, Fabienne;
Woyach, Jennifer A.

Publication type:

journal article

Rucaparib: A Review in Ovarian Cancer.

Published in:

2019

By:

Shirley, Matt

Publication type:

journal article

Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib.

Published in:

2019

By:

Zhao, Yiming;
Wang, Shuyuan;
Zhang, Bo;
Qiao, Rong;
Xu, Jianlin;
Zhang, Lele;
Zhang, Yanwei;
Han, Baohui

Publication type:

journal article

Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models.

Published in:

2019

By:

Yee, Pei San;
Zainal, Nur Syafinaz;
Gan, Chai Phei;
Lee, Bernard K. B.;
Mun, Kein Seong;
Abraham, Mannil Thomas;
Ismail, Siti Mazlipah;
Abdul Rahman, Zainal Ariff;
Patel, Vyomesh;
Cheong, Sok Ching

Publication type:

journal article

Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.

Published in:

2019

By:

Chen, Xiang;
Yao, JiaXi;
Liu, Li;
Zheng, WenZhong;
Hu, XiaoYi;
Zhu, YanJun;
Wang, Hang;
Guo, JianMing

Publication type:

journal article

The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and Immunotherapies.

Published in:

2019

By:

Marquardt, Jens U.;
Saborowski, Anna;
Czauderna, Carolin;
Vogel, Arndt

Publication type:

journal article

EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR.

Published in:

2019

By:

Buder, Anna;
Setinek, Ulrike;
Hochmair, Maximilian J.;
Schwab, Sophia;
Kirchbacher, Klaus;
Keck, Andrea;
Burghuber, Otto C.;
Pirker, Robert;
Filipits, Martin

Publication type:

journal article